The study found that nobiletin can simultaneously inhibit the ERK1/2 and PI3K/AKT pathways to suppress the growth of TNBC MDA-MB-468 cells and perform anti-tumor effects through anti-proliferation and induction of apoptosis [109]. Here, AKT1 is linked to neoplasm.